Medical News

RSS

Majority of U.S. adults strongly support innovative programs to discourage teen pregnancy

Every hour in the United States, about 40 children are born to teenage mothers. Americans consistently rate teen pregnancy as one of the top 10 biggest health problems for young people and the U.S. still has the highest teen birth rate among all industrialized countries -- despite decreases in the birth rate during the past 20 years.

7 Jan 2011

Babies' brains process language the same way as adults

Babies, even those too young to talk, can understand many of the words that adults are saying - and their brains process them in a grown-up way.

7 Jan 2011

Impulse Monitoring announces acquisition of Great Lakes Intraoperative Monitoring

Impulse Monitoring, Inc. (IMI), a leading provider of intraoperative neurophysiologic monitoring (IONM) services to hospitals, today announced that it has acquired the assets of Great Lakes Intraoperative Monitoring, LP (GLIM), a subsidiary of Williamsville, NY-based Archer Medical Diagnostic Testing, Inc.

7 Jan 2011

NovaDel receives $500,000 milestone payment from Akrimax in connection with NitroMist agreement

NovaDel Pharma Inc. today announced that it has received a $500,000 milestone payment from Akrimax Pharmaceuticals. The milestone payment was received in connection with the license and distribution agreement, dated October 27, 2009, between NovaDel Pharma Inc. and Mist Acquisition, LLC, an affiliate of Akrimax Pharmaceuticals.

7 Jan 2011

Unexpected discovery holds promise for PTSD, other anxiety disorders

An unexpected discovery by UCLA life scientists holds promise for the future development of treatments for post-traumatic stress disorder and other anxiety disorders, and potentially for Alzheimer's disease and other memory-impairment diseases.

7 Jan 2011

ADA commends HHS for reaffirming safety, efficacy of optimal community water fluoridation

The American Dental Association (ADA) today commended the Federal agencies responsible for public health and safety for recalibrating the ratio of fluoride to water that they consider optimal based on scientific evaluation and the full appreciation of fluoride received from all sources.

7 Jan 2011

Underwriters exercise over-allotment option in Amarin ADS public offering

Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that, in connection with its previously announced underwritten public offering of American Depositary Shares ("ADSs"), the underwriters of the offering have exercised in full their option to purchase up to an aggregate of 1,800,000 additional ADSs to cover over-allotments.

7 Jan 2011

Sutro, Pfizer enter multi-year collaboration for novel peptide-based therapeutics

Sutro Biopharma, a biopharmaceutical company developing novel and biosuperior protein therapeutics with improved pharmaceutical properties, today announced that the company has entered into a multi-year collaboration with Pfizer for the research, development and commercialization of novel peptide-based therapeutics.

7 Jan 2011

Radiosurgery may bring improvement for patients with extremely severe -compulsive disorder

For patients with extremely severe -compulsive disorder (OCD), a procedure called radiosurgery may bring improvement when other treatments have failed, according to a study in the January issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

7 Jan 2011

Aratana closes $20 million Series A financing

Aratana Therapeutics, a newly-formed company focused on the development of innovative therapies for the animal health industry, today announced that it has closed a $20 million Series A financing led by MPM Capital and Avalon Ventures.

7 Jan 2011

Critical Diagnostics' high sensitivity Presage ST2 Assay receives CE Mark approval

Critical Diagnostics announced today that it has received CE (Conformité Européenne) Mark for its high sensitivity Presage ST2 Assay and is commencing commercialization in Europe. The product is indicated for use as an aid in risk stratification of patients with heart failure or acute coronary syndrome. This regulatory milestone marks the first time that an assay has become commercially available for the clinical measurement of the biomarker soluble ST2.

7 Jan 2011

MMRF awards $3 million under 2010 Biotech Investment Awards program

The Multiple Myeloma Research Foundation (MMRF) today announced that it has awarded $1 million to each of three Boston-area biotech companies through its 2010 Biotech Investment Awards program: Constellation Pharmaceuticals, Inc., Epizyme, Inc. and Karyopharm Therapeutics, Inc. Since the inception of this MMRF program in 2006, $11 million has been committed to 11 biotech companies in multi-year, results-driven funding for the development of innovative treatments for patients with multiple myeloma.

7 Jan 2011

Low incentive fails to 'switch off' brain regions involved in mind-wandering among ADHD children

Brain scans of children with attention-deficit/hyperactivity disorder (ADHD) have shown for the first time why people affected by the condition sometimes have difficulty in concentrating. The study, by experts at The University of Nottingham, may explain why parents often say that their child can maintain concentration when they are doing something that interests them, but struggles with boring tasks.

7 Jan 2011

Chimerix initiates enrollment in CMX001 clinical study for life-threatening conditions caused by dsDNA viruses

Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced that patient enrollment has begun in a multicenter, open-label clinical study of CMX001 (the CMX001-350 study) for the treatment of life-threatening or serious conditions caused by double-stranded DNA (dsDNA) viruses.

7 Jan 2011

Research roundup: Accountable Care Organizations; Electronic health records; Medicaid and deficit reductions

Health Affairs: Accountable Care Organizations: Making Them Work - The January issue of the journal features several articles examining initiatives underway that could help form ACOs, such as Blue Cross Blue Shield of Massachusetts' "Alternative Quality Contract,"a modified global payment model in which annual payments to medical groups are linked to a per member per month budget.

7 Jan 2011

Amorfix's AD diagnostic assay detects aggregated beta amyloid in spinal fluid

Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced preliminary results indicating that their human Alzheimer's disease (AD) diagnostic assay can detect a signal from aggregated beta amyloid in the spinal fluid (CSF) from AD patients.

7 Jan 2011

Roundup: Calif. and health reform; Conn. mental health parity; Insurance premium increases in Iowa, Fla.

Wellmark Blue Cross and Blue Shield's proposed 11 percent health insurance premium increase is excessive, two experts have concluded. The company, which insures three-quarters of Iowans who buy their own policies, already raised premiums on those plans an average of 18 percent last spring. Wellmark sparked outcries when it announced in November that it wants to raise those rates again in order to keep up with rising prices and increased use of medical care (Leys, 1/7).

7 Jan 2011

DARA regains compliance for continued listing on The NASDAQ Capital Market

DARA BioSciences, Inc. today announced that, on January 5, 2011, NASDAQ notified the Company that it has regained compliance with the minimum stockholders' equity requirement for continued listing on The NASDAQ Capital Market, as set forth in NASDAQ Listing Rule 5550(b)(1).

7 Jan 2011

FDA approved KOMBIGLYZE XR for type 2 diabetes mellitus now available in pharmacies

Bristol-Myers Squibb Company, and AstraZeneca today announced that KOMBIGLYZE™ XR (saxagliptin and metformin HCl extended-release), approved by the U.S. Food and Drug Administration (FDA) on November 5, 2010, is now available by prescription in pharmacies across the United States.

7 Jan 2011

GOP governors seek leeway to cut Medicaid rolls, The Wall Street Journal reports

Republican governors are pressing the Obama administration to make it easier for states to cut Medicaid enrollment, setting up a fight over one of states' costliest programs (Adamy, 1/7).

7 Jan 2011

Medical News

Majority of U.S. adults strongly support innovative programs to discourage teen pregnancy

Babies' brains process language the same way as adults

Impulse Monitoring announces acquisition of Great Lakes Intraoperative Monitoring

NovaDel receives $500,000 milestone payment from Akrimax in connection with NitroMist agreement

Unexpected discovery holds promise for PTSD, other anxiety disorders

ADA commends HHS for reaffirming safety, efficacy of optimal community water fluoridation

Underwriters exercise over-allotment option in Amarin ADS public offering

Sutro, Pfizer enter multi-year collaboration for novel peptide-based therapeutics

Radiosurgery may bring improvement for patients with extremely severe -compulsive disorder

Aratana closes $20 million Series A financing

Critical Diagnostics' high sensitivity Presage ST2 Assay receives CE Mark approval

MMRF awards $3 million under 2010 Biotech Investment Awards program

Low incentive fails to 'switch off' brain regions involved in mind-wandering among ADHD children

Chimerix initiates enrollment in CMX001 clinical study for life-threatening conditions caused by dsDNA viruses

Research roundup: Accountable Care Organizations; Electronic health records; Medicaid and deficit reductions

Amorfix's AD diagnostic assay detects aggregated beta amyloid in spinal fluid

Roundup: Calif. and health reform; Conn. mental health parity; Insurance premium increases in Iowa, Fla.

DARA regains compliance for continued listing on The NASDAQ Capital Market

FDA approved KOMBIGLYZE XR for type 2 diabetes mellitus now available in pharmacies

GOP governors seek leeway to cut Medicaid rolls, The Wall Street Journal reports

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News